{
PerkinElmer Inc

Companies

}
001122334455554433221100
001122334455554433221100

lateral flow assay market analysis trends and growth opportunities 2024 to 2031

Priya Pandey, a biotechnology graduate, excels in creating engaging content across various industries, including healthcare and technology. Coherent Market Insights offers comprehensive market intelligence and consulting services, providing detailed reports on sectors like food and beverages and pharmaceuticals, with insights into market dynamics and competitive strategies. The latest report on the Lateral Flow Assay Market forecasts trends and growth from 2024 to 2031, analyzing consumer behavior and regulatory factors while highlighting key players and emerging opportunities.
EIN News
United States Dollar QuidelOrtho Corporation Hologic Inc Thermo Fisher Scientific Inc. QIAGEN NV Siemens AG Abcam plc PerkinElmer Inc Danaher Corporation Eiken Chemical Co., Ltd. Becton, Dickinson and Company Merck KGaA Bio-Rad Laboratories Inc Abbott Laboratories F. Hoffmann-La Roche Ltd. Biomerieux SA FRA ARG NZL CAN TUR SAU ARE USA RUS IND AUS ESP GBR SGP BRA IRN CHN DEU MEX ITA JPN Priya Pandey Show more
Healthcare, Market Report
09:06 10.01.2025

growth opportunities in the tuberculosis diagnostics market through 2033

The global tuberculosis diagnostics market, valued at approximately $2.05 billion in 2023, is projected to grow to $3.6 billion by 2033, driven by advancements in nucleic acid testing and increasing healthcare investments. Key opportunities lie in smear microscopy, active tuberculosis detection, and hospital diagnostics, with significant growth expected in the Asia-Pacific and North America regions. Major players include Beckton, Dickinson and Company, Qiagen, and F. Hoffmann-La Roche, collectively holding a substantial market share.
globenewswire.com
Euro United States Dollar Bio-Techne Corporation Thermo Fisher Scientific Inc. Qiagen N.V. Bio-Rad Laboratories, Inc. PerkinElmer Inc Becton, Dickinson and Company BioMerieux SA Abbott Laboratories USA Show more
Healthcare, Market Report
10:21 06.01.2025

global clinical biomarkers market projected to reach 47 billion by 2031

The global clinical biomarkers market, valued at $25.02 billion in 2023, is projected to reach $47.25 billion by 2031, growing at a CAGR of 8.54%. This growth is driven by rising cancer cases and advancements in diagnostic technologies, despite challenges like high costs and reimbursement issues. Key players include Roche, Abbott, and Johnson & Johnson, with significant developments in biomarker testing for various diseases.
openPR.com
Eurofins Scientific S.E. A PerkinElmer Inc Johnson & Johnson Services Inc. Bio-Rad Laboratories, Inc. Qiagen N.V. Merck KGaA Thermo Fisher Scientific Inc. General Electric Co Siemens Healthineers AG Agilent Technologies, Inc. F. Hoffmann-La Roche Ltd. USA Show more
Healthcare, Market Report
08:45 16.12.2024
Trending
Subcategory
Industry Trends Corporate News Supply Chain Management Global Trade Developments Startups & Entrepreneurship Government Economic Policies Industry Mergers & Acquisitions Retail and Consumer Goods Finance Mergers & Acquisitions Financial Scams and Security Fintech Startups Emerging Startups Workplace Trends CEO Changes Venture Capital Investments Cryptocurrency Trends Funding Rounds & Investments Energy Sector Developments Market Analysis and Predictions Stock Market Updates
Countries:
USA IND CHN ARE VNM MAR JPN EGY SAU CAN MEX HKG KOR SGP THA PAK DZA TWN NLD FRA
Companies:
Apple Inc. Google Inc. NVIDIA Corporation Delhivery Limited Ecom Express Ltd. Alphabet Inc. OpenAI ERC USD Ciscom Corp. ERICSSON - CLASS B Physicswallah Ltd. Learning Resources Inc. MGA Entertainment Inc. State Street Global Advisors Luxembourg SICAV - SSGA EMU ESG Screened Equity Fund Snap Inc. Tiktok USD Semiconductor Manufacturing International Corporation Hua Hong Semiconductor Ltd. Spotify Technology S.A. Dropbox, Inc. Vimeo, Inc.
Currencies:
United States Dollar Indian Rupee Chinese Yuan Euro United Arab Emirates Dirham Vietnamese Đồng New Taiwan Dollar Russian Ruble South Korean Won Pakistani Rupee Algerian Dinar Australian Dollar Thai Baht Japanese Yen Saudi Riyal
People:
Donald Trump Ilya Sutskever Peter Thiel Amal El Fallah Seghrouchni Trixie Lohmirmand Scott Bessent Jamieson Greer Joe Jurken Stephen Roachford David French Rick Woldenberg Marc Rosenberg Isaac Larian Hichem Djouhri Laurina Emmanuel Tim Cook Andrew Ferguson Sheryl Sandberg Mark Zuckerberg Pavel Prass

Machinary offers a groundbreaking, modular, and customizable solution that provides advanced financial news and statistical analysis. Our platform goes beyond traditional quantitative analysis, offering users a comprehensive understanding of real-time market dynamics, event detection, and risk analysis.

Links

Address

Newsletter

© 2025 by Machinary.com - Version: 1.0.0.0. All rights reserved

Layout

Color mode

Theme mode

Layout settings

Save settings
Reset settings
Seems like the connection with the server has been lost. It can be due to poor or broken network. Please hang on while we're trying to reconnect...
Oh snap! Failed to reconnect with the server. This is typically caused by a longer network outage, or if the server has been taken down. You can try to reconnect, but if that does not work, you need to reload the page.
Oh man! The server rejected the attempt to reconnect. The only option now is to reload the page, but be prepared that it won't work, since this is typically caused by a failure on the server.